• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过静脉注射递送至大脑的神经递质衍生类脂(NT-lipidoids)。

Neurotransmitter-derived lipidoids (NT-lipidoids) for enhanced brain delivery through intravenous injection.

机构信息

Department of Biomedical Engineering, Tufts University, 4 Colby Street, Medford, MA 02155, USA.

出版信息

Sci Adv. 2020 Jul 24;6(30):eabb4429. doi: 10.1126/sciadv.abb4429. eCollection 2020 Jul.

DOI:10.1126/sciadv.abb4429
PMID:32832671
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7439549/
Abstract

Safe and efficient delivery of blood-brain barrier (BBB)-impermeable cargos into the brain through intravenous injection remains a challenge. Here, we developed a previously unknown class of neurotransmitter-derived lipidoids (NT-lipidoids) as simple and effective carriers for enhanced brain delivery of several BBB-impermeable cargos. Doping the NT-lipidoids into BBB-impermeable lipid nanoparticles (LNPs) gave the LNPs the ability to cross the BBB. Using this brain delivery platform, we successfully delivered amphotericin B (AmB), antisense oligonucleotides (ASOs) against tau, and genome-editing fusion protein (-27)GFP-Cre recombinase into the mouse brain via systemic intravenous administration. We demonstrated that the NT-lipidoid formulation not only facilitates cargo crossing of the BBB, but also delivery of the cargo into neuronal cells for functional gene silencing or gene recombination. This class of brain delivery lipid formulations holds great potential in the treatment of central nervous system diseases or as a tool to study the brain function.

摘要

通过静脉注射将血脑屏障(BBB)不可渗透的有效载荷安全有效地递送到大脑仍然是一个挑战。在这里,我们开发了一类以前未知的神经递质衍生脂质体(NT-脂质体),作为增强几种 BBB 不可渗透的有效载荷脑内传递的简单有效的载体。将 NT-脂质体掺杂到 BBB 不可渗透的脂质纳米颗粒(LNPs)中,使 LNPs 具有穿过 BBB 的能力。使用这种脑内传递平台,我们通过系统静脉内给药成功地将两性霉素 B(AmB)、针对 tau 的反义寡核苷酸(ASO)和基因组编辑融合蛋白(-27)GFP-Cre 重组酶递送到小鼠大脑中。我们证明,NT-脂质体配方不仅促进了货物穿过 BBB,还将货物递送到神经元细胞中,以实现功能性基因沉默或基因重组。这类脑内传递脂质制剂在治疗中枢神经系统疾病或作为研究大脑功能的工具方面具有巨大的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a5/7439549/132c63f1fab6/abb4429-F4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a5/7439549/58a552a672fa/abb4429-F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a5/7439549/fbd25dba7f84/abb4429-F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a5/7439549/293dde57afc3/abb4429-F3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a5/7439549/132c63f1fab6/abb4429-F4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a5/7439549/58a552a672fa/abb4429-F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a5/7439549/fbd25dba7f84/abb4429-F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a5/7439549/293dde57afc3/abb4429-F3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a5/7439549/132c63f1fab6/abb4429-F4.jpg

相似文献

1
Neurotransmitter-derived lipidoids (NT-lipidoids) for enhanced brain delivery through intravenous injection.通过静脉注射递送至大脑的神经递质衍生类脂(NT-lipidoids)。
Sci Adv. 2020 Jul 24;6(30):eabb4429. doi: 10.1126/sciadv.abb4429. eCollection 2020 Jul.
2
Combinatorial library of chalcogen-containing lipidoids for intracellular delivery of genome-editing proteins.含硫脂脂质体组合文库用于基因编辑蛋白的细胞内递送。
Biomaterials. 2018 Sep;178:652-662. doi: 10.1016/j.biomaterials.2018.03.011. Epub 2018 Mar 8.
3
Predictive High-Throughput Platform for Dual Screening of mRNA Lipid Nanoparticle Blood-Brain Barrier Transfection and Crossing.用于 mRNA 脂质纳米颗粒血脑屏障转染和穿越的双重筛选的高通量预测平台。
Nano Lett. 2024 Feb 7;24(5):1477-1486. doi: 10.1021/acs.nanolett.3c03509. Epub 2024 Jan 23.
4
Combinatorial Library of Light-Cleavable Lipidoid Nanoparticles for Intracellular Drug Delivery.用于细胞内药物递送的可光裂解类脂质纳米颗粒组合文库。
ACS Biomater Sci Eng. 2019 May 13;5(5):2391-2398. doi: 10.1021/acsbiomaterials.9b00445. Epub 2019 Apr 23.
5
and Study of Amphotericin B Formulation with Quaternized Bioreducible Lipidoids.两性霉素B与季铵化生物可还原类脂质体配方的研究
ACS Biomater Sci Eng. 2020 Feb 10;6(2):1064-1073. doi: 10.1021/acsbiomaterials.9b01722. Epub 2020 Jan 22.
6
In situ combinatorial synthesis of degradable branched lipidoids for systemic delivery of mRNA therapeutics and gene editors.用于 mRNA 治疗药物和基因编辑系统递释的可降解分支型脂质体的原位组合合成。
Nat Commun. 2024 Feb 26;15(1):1762. doi: 10.1038/s41467-024-45537-z.
7
Lipid nanoparticles strategies to modify pharmacokinetics of central nervous system targeting drugs: Crossing or circumventing the blood-brain barrier (BBB) to manage neurological disorders.脂质纳米粒策略修饰脑靶向药物的药代动力学:穿越或绕过血脑屏障(BBB)以治疗神经疾病。
Adv Drug Deliv Rev. 2022 Oct;189:114485. doi: 10.1016/j.addr.2022.114485. Epub 2022 Aug 12.
8
Lipid nanoparticle formulations for optimal RNA-based topical delivery to murine airways.用于优化基于 RNA 的经皮递送至小鼠气道的脂质纳米颗粒制剂。
Eur J Pharm Sci. 2022 Sep 1;176:106234. doi: 10.1016/j.ejps.2022.106234. Epub 2022 Jun 8.
9
Development and screening of brain-targeted lipid-based nanoparticles with enhanced cell penetration and gene delivery properties.脑靶向脂质纳米粒的构建与筛选及其增强的细胞穿透和基因传递性能。
Int J Nanomedicine. 2019 Aug 14;14:6497-6517. doi: 10.2147/IJN.S215941. eCollection 2019.
10
Immunogenicity Testing of Lipidoids In Vitro and In Silico: Modulating Lipidoid-Mediated TLR4 Activation by Nanoparticle Design.类脂分子的体外和计算机模拟免疫原性测试:通过纳米颗粒设计调控类脂分子介导的TLR4激活
Mol Ther Nucleic Acids. 2018 Jun 1;11:159-169. doi: 10.1016/j.omtn.2018.02.003. Epub 2018 Feb 13.

引用本文的文献

1
Lipid nanoparticles for mRNA delivery in brain via systemic administration.通过全身给药用于脑内mRNA递送的脂质纳米颗粒。
Sci Adv. 2025 Aug 15;11(33):eadw0730. doi: 10.1126/sciadv.adw0730. Epub 2025 Aug 13.
2
Tryptamine-Functionalized Lipid Nanocarriers Co-delivering SMO/BRD4 Inhibitors for Synergistic Medulloblastoma Therapy.用于协同性髓母细胞瘤治疗的共递送SMO/BRD4抑制剂的色胺功能化脂质纳米载体
Biomater Res. 2025 Aug 8;29:0237. doi: 10.34133/bmr.0237. eCollection 2025.
3
demonstration of enhanced mRNA delivery by cyclic disulfide-containing lipid nanoparticles for facilitating endosomal escape.

本文引用的文献

1
and Study of Amphotericin B Formulation with Quaternized Bioreducible Lipidoids.两性霉素B与季铵化生物可还原类脂质体配方的研究
ACS Biomater Sci Eng. 2020 Feb 10;6(2):1064-1073. doi: 10.1021/acsbiomaterials.9b01722. Epub 2020 Jan 22.
2
Efficient Delivery of Antisense Oligonucleotides Using Bioreducible Lipid Nanoparticles In Vitro and In Vivo.使用可生物还原脂质纳米颗粒在体外和体内有效递送反义寡核苷酸
Mol Ther Nucleic Acids. 2020 Mar 6;19:1357-1367. doi: 10.1016/j.omtn.2020.01.018. Epub 2020 Jan 25.
3
Cell-Selective Messenger RNA Delivery and CRISPR/Cas9 Genome Editing by Modulating the Interface of Phenylboronic Acid-Derived Lipid Nanoparticles and Cellular Surface Sialic Acid.
含环状二硫键的脂质纳米颗粒增强mRNA递送以促进内体逃逸的证明。
RSC Med Chem. 2025 Jun 27. doi: 10.1039/d5md00084j.
4
Synthetic Biology-Based Engineering Cells for Drug Delivery.基于合成生物学的药物递送工程细胞
Exploration (Beijing). 2025 Jan 16;5(2):20240095. doi: 10.1002/EXP.20240095. eCollection 2025 Apr.
5
Transferrin and Borneol-Enhanced Liposomes for Targeted Rapamycin Delivery in TBI.转铁蛋白与冰片增强脂质体用于创伤性脑损伤中雷帕霉素的靶向递送
Int J Nanomedicine. 2025 Apr 11;20:4503-4518. doi: 10.2147/IJN.S489165. eCollection 2025.
6
Therapeutic Delivery of circDYM by Perillyl Alcohol Nanoemulsion Alleviates LPS-Induced Depressive-Like Behaviors.紫苏醇纳米乳剂对circDYM的治疗性递送减轻脂多糖诱导的抑郁样行为
Adv Sci (Weinh). 2025 Jun;12(21):e2414559. doi: 10.1002/advs.202414559. Epub 2025 Mar 27.
7
Targeting Neuroinflammation in Central Nervous System Diseases by Oral Delivery of Lipid Nanoparticles.通过口服脂质纳米颗粒靶向中枢神经系统疾病中的神经炎症
Pharmaceutics. 2025 Mar 18;17(3):388. doi: 10.3390/pharmaceutics17030388.
8
Designer lipids for delivering mRNA to the brain.用于将mRNA递送至大脑的设计脂质。
Nat Mater. 2025 Mar 24. doi: 10.1038/s41563-025-02184-z.
9
Lipid Nanoparticles for mRNA Delivery in Cancer Immunotherapy.用于癌症免疫治疗中mRNA递送的脂质纳米颗粒
AAPS J. 2025 Mar 18;27(3):66. doi: 10.1208/s12248-025-01051-8.
10
Optimization of Lipid Nanoparticles with Robust Efficiency for the Delivery of Protein Therapeutics to Augment Cancer Immunotherapy.用于递送蛋白质疗法以增强癌症免疫疗法的高效脂质纳米颗粒的优化。
Adv Sci (Weinh). 2025 May;12(17):e2500844. doi: 10.1002/advs.202500844. Epub 2025 Mar 8.
通过调节苯硼酸衍生脂质纳米颗粒与细胞表面唾液酸的界面实现细胞选择性信使 RNA 传递和 CRISPR/Cas9 基因组编辑。
ACS Appl Mater Interfaces. 2019 Dec 18;11(50):46585-46590. doi: 10.1021/acsami.9b17749. Epub 2019 Dec 9.
4
Wrangling RNA: Antisense oligonucleotides for neurological disorders.RNA 疗法:反义寡核苷酸治疗神经疾病。
Sci Transl Med. 2019 Sep 25;11(511). doi: 10.1126/scitranslmed.aay2069.
5
Sustained delivery and molecular targeting of a therapeutic monoclonal antibody to metastases in the central nervous system of mice.在小鼠中枢神经系统转移灶中实现治疗性单克隆抗体的持续递释和分子靶向。
Nat Biomed Eng. 2019 Sep;3(9):706-716. doi: 10.1038/s41551-019-0434-z. Epub 2019 Aug 5.
6
Integrating Combinatorial Lipid Nanoparticle and Chemically Modified Protein for Intracellular Delivery and Genome Editing.组合脂质纳米颗粒与化学修饰蛋白在细胞内递送和基因组编辑中的整合应用。
Acc Chem Res. 2019 Mar 19;52(3):665-675. doi: 10.1021/acs.accounts.8b00493. Epub 2018 Dec 26.
7
Current Strategies for Brain Drug Delivery.当前的脑内药物递送策略。
Theranostics. 2018 Feb 5;8(6):1481-1493. doi: 10.7150/thno.21254. eCollection 2018.
8
Crossing the blood-brain barrier with nanoparticles.纳米颗粒穿越血脑屏障。
J Control Release. 2018 Jan 28;270:290-303. doi: 10.1016/j.jconrel.2017.12.015. Epub 2017 Dec 19.
9
Antisense oligonucleotides: the next frontier for treatment of neurological disorders.反义寡核苷酸:治疗神经紊乱的下一个前沿。
Nat Rev Neurol. 2018 Jan;14(1):9-21. doi: 10.1038/nrneurol.2017.148. Epub 2017 Dec 1.
10
Delivery of Biologics Across the Blood-Brain Barrier with Molecular Trojan Horse Technology.利用分子木马技术将生物制剂递送到血脑屏障。
BioDrugs. 2017 Dec;31(6):503-519. doi: 10.1007/s40259-017-0248-z.